Nagging inner-elbow pain that keeps coming back? A structured, surgeon-led tendon plan for golfer's elbow that addresses the tendon, not just the symptom.
Golfer's elbow — medial epicondylitis — is the inner-elbow counterpart to tennis elbow: a degenerative tendon problem where the flexor tendons attach. It nags with gripping and wrist flexion, flares with golf, racket sports, and lifting, and rarely resolves with rest alone. Chronos treats it as a tendon that needs the right loading, guided by a board-certified orthopedic surgeon.
Care runs through the Tendon Optimization Program. A plan typically centers on progressive, tendon-specific loading, with treatment modalities such as extracorporeal shockwave therapy sequenced to the phase of healing. Where appropriate, Chronos also evaluates a range of orthobiologic and regenerative options — including peptide and emerging cellular (stem cell–derived) approaches, and high-dose PRP where appropriate — discussed individually and under informed consent. Many are investigational and not FDA-approved; whether any is reasonable for you is a clinical decision, not a guaranteed outcome. We also check the ulnar nerve, which can be involved in medial elbow pain. Surgery is rarely needed and reserved for cases that fail a well-structured program.
Both are tendon problems at the elbow. Golfer's elbow (medial epicondylitis) affects the inner elbow and flexor tendons; tennis elbow (lateral epicondylitis) affects the outer elbow and extensor tendons. The treatment principles are similar.
Rarely. Most medial epicondylitis is managed without surgery through a structured tendon-loading program. Surgery is reserved for cases that fail well-structured non-surgical care.
An Initial Consultation is a focused evaluation with a board-certified orthopedic surgeon. You leave with a clear plan.
Book Initial Consultation — $250Educational information only, not medical advice, and not a guarantee of any outcome. Specific clinical decisions are made in consultation with Dr. Rahman after an individual evaluation. Some approaches discussed are investigational and not FDA-approved for these uses.